265. Lipodystrophy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 112 / Drugs : 155 - (DrugBank : 55) / Drug target genes : 25 - Drug target pathways : 97
| Previous names | - | ||
|---|---|---|---|
| Other names | - | ||
| Disease group | Endocrine diseases | ||
| Related info (in Japanese) | - | ||
| Designated intractable diseases (in Japanese) | Overview, Diagnostic criteria, etc. (docx), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 5-38-83. Lipodystrophy | ||
| 7-1-6. lipoatrophic diabetes | |||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 265-1. | Generalized congenital lipodystrophy;Berardinelli-Seip syndrome; | 5-38-83. Lipodystrophy 7-1-6. lipoatrophic diabetes | |
| 265-2. | Familial partial lipodystrophy;Dunnigan-type familial partial lipodystrophy;Kobbering-type familial partial lipodystrophy; | 5-38-83. Lipodystrophy 7-1-6. lipoatrophic diabetes | |
| 265-3. | Acquired generalized lipodystrophy;Lawrence syndrome; | 5-38-83. Lipodystrophy 7-1-6. lipoatrophic diabetes | |
| 265-4. | Partial acquired lipodystrophy;Barraquer-Simons syndrome; | 5-38-83. Lipodystrophy 7-1-6. lipoatrophic diabetes | |